Toronto wins bid to maintain exclusive market rights for Gilead in precedent-setting data protection case
Global law firm Norton Rose Fulbright successfully represented Gilead Sciences against the first-ever challenge of data protection rights for anti-HIV combination drug therapies.
Read full press release here.
Read full press release here.